May 02, 2013
BD Announces Results for 2013 Second Fiscal Quarter
|
April 26, 2013
BD Diagnostics Advances Commitment to a Fully Integrated Microbiology Solution with New Agreement
|
April 22, 2013
FDA Approves Second Drug in BD Simplist™ Prefilled Injectable Line of Products
|
April 17, 2013
New Gastrointestinal Tract Infections Assays Launch in Europe
|
April 10, 2013
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS™ Passive Needle Guard
|
April 08, 2013
New Molecular Assay Provides Healthcare Facilities with a Simple, Efficient Way to Detect Dangerous Superbug
|
April 08, 2013
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
April 07, 2013
CML HealthCare Inc. to Install North America's First and World's Largest Fully Automated BD Kiestra™ Microbiology Platform
|
March 27, 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
|
March 13, 2013
BD Announces Appointment of Dr. Ellen Strahlman as Chief Medical Officer and Senior Vice President, Research & Development
|
March 12, 2013
BD Acquires Cato Software Solutions
|
February 27, 2013
Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
|
February 27, 2013
BD to Present at Investor Healthcare Conferences
|
February 07, 2013
BD to Present at Investor Healthcare Conferences
|
February 05, 2013
BD Announces Results for 2013 First Fiscal Quarter
|
January 29, 2013
Catherine M. Burzik Elected as BD Director
|
January 29, 2013
BD Board Declares Dividend
|
January 23, 2013
BD Announces Webcast of Annual Meeting of Shareholders
|
January 15, 2013
BD PhaSeal™ System Receives Clearance from FDA Under Newly Created ONB Product Code
|
January 08, 2013
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
December 26, 2012
BD Completes Acquisition of Safety Syringes, Inc.
|
December 21, 2012
BD to Present at Investor Healthcare Conferences
|
December 10, 2012
Medication Errors from Injectable Drugs Harm One Million Inpatients Each Year Adding Billions in Cost, New Study Finds
|
November 20, 2012
BD Board Increases Dividend by 10 Percent
|
November 07, 2012
BD Announces Results for 2012 Fourth Fiscal Quarter and Full Year
|
November 06, 2012
BD Announces Funding and Product Support for Hurricane Sandy Relief Efforts
|
November 06, 2012
BD Announces Appointment of William A. Kozy as Chief Operating Officer
|
November 01, 2012
BD Completes Sale of Majority of Discovery Labware Unit
|
October 31, 2012
First Partner Assay on the BD MAX™ System Launches in Europe
|
October 29, 2012
BD is Awarded WindMade™ Certification; Ranks Among Top 40 U.S. Companies in Newsweek's 2012 Green Rankings
|
October 17, 2012
New Molecular Test Available to Diagnose Trichomonas vaginalis in Asymptomatic and Symptomatic Females
|
October 12, 2012
BD and Lab21 Collaborate to Develop New Oncology Assays on the BD MAX™ Platform
|
October 11, 2012
New Disposable Pen Injector Offers Ease of Use as well as Customization Options for Use with a Wide Range of Injectable Drugs
|
October 10, 2012
BD Announces Chief Financial Officer Transition
|
October 02, 2012
New RSV Test Provides Reliable Results in Minutes
|
October 02, 2012
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call
|
September 28, 2012
Leading Microbiology Expert Joins BD Diagnostics in Maryland
|
September 26, 2012
New Molecular Assay Detects Rapidly Emerging Multidrug-Resistant Superbug
|
September 20, 2012
New Influenza Test Offers Labs Advanced Performance and Reliable Results
|
September 19, 2012
BD Introduces Advanced Needle Technology Designed to Enhance Patient Comfort and Improve Patient Adherence in Diabetes Care
|
September 04, 2012
New Initiative to Advance Health Workers' Blood Collection Skills
|
August 27, 2012
BD Acquires Sirigen Group Limited
|
August 14, 2012
New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
|
August 02, 2012
BD Announces Results for 2012 Third Fiscal Quarter
|
July 26, 2012
BD and PEPFAR Launch Labs for Life to Strengthen Laboratories in Regions Heavily Burdened by Disease
|
July 25, 2012
BD Launches New Needle Designed to Improve Performance and Patient Comfort
|
July 24, 2012
BD Board Declares Dividend
|
July 23, 2012
BD Board of Directors Elects Rebecca W. Rimel
|
July 16, 2012
New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards
|
July 11, 2012
BD Announces Agreement to Acquire Safety Syringes, Inc.
|
July 09, 2012
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug
|
June 28, 2012
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 20, 2012
New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications
|
June 07, 2012
JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
|
May 30, 2012
BD to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
|
May 23, 2012
BD Issues 2011 Sustainability Report
|
May 22, 2012
BD Board Declares Dividend
|
May 22, 2012
BD Appoints CEO Vincent A. Forlenza as Chairman of the Board
|
May 21, 2012
BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti
|
May 02, 2012
BD Opens Major Distribution Center in Four Oaks, North Carolina
|
May 02, 2012
BD to Present at Investor Healthcare Conferences
|
May 01, 2012
BD Announces Results for 2012 Second Fiscal Quarter
|
April 10, 2012
BD Signs Agreement to Sell Majority of Discovery Labware Unit
Advanced Bioprocessing Platform Excluded from Sale
|
April 02, 2012
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 29, 2012
New Assay Rapidly Identifies Lethal Pathogen Responsible for Clostridium difficile Infection
|
March 27, 2012
New IVD Product is Designed to Improve Prevention and Control of GBS in Newborns
|
March 26, 2012
New Collaboration Aims to Improve Access to TB Diagnostics
|
March 09, 2012
BD to Present at the Barclays Capital Global Healthcare Conference
|
March 07, 2012
Study Shows Nurses are Exposed To Risks from Blood Exposure During Insertion and Removal of Peripheral IV Catheter
|
March 01, 2012
Nationwide Educational Tour Kicks Off on the Future of Molecular Diagnostics
|
February 13, 2012
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies to Offer Integrated Microbiology Lab Solutions
|
February 13, 2012
BD Acquires KIESTRA Lab Automation BV
|
February 13, 2012
First Specimen Collection Training Curriculum in Sub-Saharan Africa Launches at Kenyan Medical Training College
|
February 10, 2012
BD to Present at Investor Healthcare Conferences
|
February 07, 2012
Mesenchymal Stem Cells Have New Cell Culture Environment
|
February 06, 2012
BD Announces Results for 2012 First Fiscal Quarter
|
January 31, 2012
BD Board Declares Dividend
|
January 24, 2012
BD Announces Webcast of Annual Meeting of Shareholders
|
January 18, 2012
BD and Mercy/ROi Collaborate to Improve Quality of Care and Reduce Costs
|
January 11, 2012
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 04, 2012
BD to Present at the 30th Annual J. P. Morgan Healthcare Conference
|
December 15, 2011
New BD Veritor™ System for Rapid Detection of Flu A+B Receives 510(k) Clearance and CLIA Waiver
|
November 23, 2011
First Healthcare-Associated Infection Assay on the BD MAX™ System Launches in Europe
|
November 22, 2011
BD Board Increases Dividend
|
November 22, 2011
BD to Present at the 23rd Annual Piper Jaffray Healthcare Conference
|
November 02, 2011
BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year
|
October 28, 2011
BD Announces 2011 Analyst Day and Webcast
|
October 27, 2011
BD Introduces the World's First Safety-Engineered Pen Needle With Passive, Dual-Ended Protection
|
October 04, 2011
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
September 26, 2011
BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity
|
September 21, 2011
BD Launches a New Generation Short Peripheral IV Catheter to Reduce Risk of Blood Exposure to Healthcare Workers
|
September 16, 2011
BD Celebrates 50 Years in Canaan, CT
|
September 13, 2011
BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®
|
September 07, 2011
BD to Present at the 2011 Morgan Stanley Global Healthcare Conference
|
August 24, 2011
BD Biosciences Announces Winners of Research Grant Program
|
August 18, 2011
BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System
|
August 17, 2011
BD Manufacturing Facility in Broken Bow Achieves Company's Landfill-Free Status
|
August 16, 2011
BD Completes Acquisition of Carmel Pharma
|
August 15, 2011
BD Launches Family of Syringes Which Addresses Environmental Impact and Meets a Variety of Clinical Needs
|
August 03, 2011
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System
|
August 02, 2011
BD Announces Results for 2011 Third Fiscal Quarter
|
July 27, 2011
BD Announces Agreement to Acquire Carmel Pharma, Inc.
|
July 26, 2011
BD Board Declares Dividend
|
July 26, 2011
BD Board of Directors Elects Vincent A. Forlenza as Next Chief Executive Officer, Effective October 1, 2011
|
July 12, 2011
BD Biosciences Announces Spring 2011 Winners of Research Grant Program
|
July 08, 2011
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
July 07, 2011
SANYO and BD Biosciences Collaborate to Offer Researchers Valuable Technology and Research Tools
|
July 06, 2011
BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline
|
June 29, 2011
BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production
|
June 20, 2011
Healthcare Workers Learn Improved Blood Collection Skills
|
June 09, 2011
Winning Photographers Bring Hope for a Healthy World
|
June 09, 2011
BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti
|
June 03, 2011
BD Celebrates Grand Opening of North American Professional Service Center in San Antonio, Texas
|
May 24, 2011
BD Board Declares Dividend
|
May 20, 2011
BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow
|
May 19, 2011
BD Issues 2010 Sustainability Report
|
May 19, 2011
BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases
|
May 09, 2011
BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System
|
May 06, 2011
BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians
|
May 03, 2011
Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion
|
April 28, 2011
BD to Present at Investor Healthcare Conferences
|
April 26, 2011
BD Announces Results for 2011 Second Fiscal Quarter
|
April 15, 2011
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
April 14, 2011
BD Celebrates Expansion of Manufacturing Facility in Columbus, Nebraska
|
April 13, 2011
BD and Waste Management Launch Initiative to Recycle Medical Sharps
|
April 07, 2011
World Health Day Emphasis on Antimicrobial Resistance Brings Much-Needed Awareness to Alarming Issue
|
April 05, 2011
BD Update Regarding Operations in Japan
|
April 04, 2011
New CDC Guidelines Recognize Value of Split Septum IV Access Technology to Reduce Intravascular Catheter-Related Bloodstream Infections
|
March 28, 2011
BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens
|
March 21, 2011
World TB Day Donation Campaign Increases Access to Improved TB Tests in Resource-Limited Settings
|
March 18, 2011
BD Completes Acquisition of Accuri Cytometers, Inc.
|
March 15, 2011
BD Statement Regarding Impact of Japan Earthquake
|
March 15, 2011
BD Donates $325,000 for Japan Earthquake and Tsunami Relief Efforts
|
February 16, 2011
BD Expands Industrial Microbiology Rapid Methods Portfolio
|
February 09, 2011
BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers
|
February 08, 2011
CEO Ed Ludwig Discusses Q1 FY11 Results on CNBC
|
February 07, 2011
BD Announces Results for 2011 First Fiscal Quarter
|
February 07, 2011
BD Announces Agreement to Acquire Accuri Cytometers, Inc.
|
February 01, 2011
BD Board Declares Dividend
|
February 01, 2011
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 24, 2011
BD and Rady Children's Hospital-San Diego Announce Innovative Pilot Project to Reduce Environmental Impact of Sharps Disposal
|
January 05, 2011
BD Announces Webcast of Annual Meeting of Shareholders
|
January 04, 2011
BD to Present at the 29th Annual J. P. Morgan Healthcare Conference
|
January 03, 2011
New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients
|
December 20, 2010
BD Diagnostics Facility in Mebane, North Carolina Achieves LEED Silver Certification for Green Building Design
|
December 16, 2010
BD Biosciences Announces Winners of Research Grant Program
|
December 02, 2010
BD - Canada Headquarters in Mississauga, Ontario Achieves LEED Gold Certification for Environmentally Responsible Design, Construction and Operations
|
November 29, 2010
Hospitals Can Save 25 Percent in Component Costs and Significantly Improve Nurse Satisfaction
|
November 23, 2010
BD Board Increases Dividend
|
November 16, 2010
BD Taps Leading Voice in Infection Prevention Community to Advance Efforts to Reduce Healthcare-Associated Infections
|
November 03, 2010
BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year
|
November 02, 2010
UPDATE: BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 25, 2010
BD Vacutainer® Rapid Serum Tube (RST) Helps Improve Healthcare Worker Safety, Patient Care and Hospital Productivity
|
October 25, 2010
BD Ranks Among Top 25 U.S. Companies in Newsweek's 2010 Green Rankings; Receives EPA Green Power Leadership Award; Named to Dow Jones Sustainability World Index for Fifth Consecutive Year
|
October 25, 2010
BD Diagnostics and Lonza Collaborate to Commercialize the Lonza microCompass™ Molecular Assays on the BD MAX™ System
|
October 14, 2010
BD Celebrates Grand Opening of New Bioscience Production Facility in Miami
|
October 14, 2010
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 01, 2010
BD to Establish Major Distribution Center in Four Oaks, North Carolina
|
September 29, 2010
BD Diagnostics and Bruker Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing
|
August 03, 2010
BD Receives CLIA "Moderate Complexity" Status for the BD MAX™ GBS Assay
|
August 02, 2010
BD Completes Sales of Ophthalmic Systems Unit and Surgical Blades Product Platform
|
July 29, 2010
BD Announces Results for Third Quarter Fiscal 2010
|
July 29, 2010
CEO Ed Ludwig Appears on CNBC to Discuss Q310 Results
|
July 28, 2010
BD Announces Promotion of President Vince Forlenza; Gains Additional Title of Chief Operating Officer
|
July 28, 2010
BD Announces Appointment of Zachary A. Nagle as Vice President, Investor Relations
|
July 27, 2010
BD Board Declares Dividend
|
July 26, 2010
BD Board of Directors Elects Christopher Jones
|
July 19, 2010
BD Biosciences Introduces CD4 Testing Product That Does Not Require Refrigeration
|
July 07, 2010
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 21, 2010
BD and PEPFAR Collaboration Initiates Program to Improve Blood-Drawing Practices in Clinics and Hospitals in Sub-Saharan Africa
|
June 17, 2010
Launch of BD BACTEC™ MGIT™ 320 System Expands TB Detection Worldwide
|
June 16, 2010
BD Biosciences to Fund $100,000 in Stem Cell Research Grants
|
June 09, 2010
BD to Present at Goldman Sachs 31st Annual Global Healthcare Conference
|
June 08, 2010
BD Signs Agreements to Sell Ophthalmic Systems Unit, Other Platforms
|
June 07, 2010
BD Launches World's Smallest Pen Needle
|
June 03, 2010
BD Issues 2009 Sustainability Report
|
June 03, 2010
BD Biosciences Announces Second Set of Winners of Expanded Research Grant Program
|
June 02, 2010
BD Announces First FDA-Cleared Assay on the BD MAX™ System to Detect Group B Streptococcus
|
June 01, 2010
BD Announces U.S. Launch of BD Vacutainer® Push Button Blood Collection Set with Pre-Attached Holder
|
May 25, 2010
BD Board Declares Dividend
|
May 20, 2010
BD Celebrates Opening of Manufacturing Facility in Mebane, North Carolina
|
May 07, 2010
BD Biosciences Launches Adaptable 7-Laser Flow Cytometry System for Advanced Research Applications
|
May 06, 2010
BD Reaffirms Commitment to GS1 Data Standards
|
May 05, 2010
BD to Present at Investor Healthcare Conferences
|
April 29, 2010
BD Announces Results for Second Quarter Fiscal 2010
|
April 14, 2010
BD Biosciences Launches New BD LSRFortessa™ Cell Analyzer
|
April 08, 2010
BD Celebrates Opening of New Manufacturing Facility in Tatabánya, Hungary
|
April 08, 2010
BD Announces Live Webcast of Second Quarter Fiscal 2010 Earnings Conference Call
|
April 06, 2010
BD Expands Diagnostics Portfolio with Advanced Automated Microbiology Specimen Processor
|
March 18, 2010
BD Diagnostics Launches the BD Protect™ Infection Surveillance and Prevention Software Portfolio
|
March 15, 2010
BD to Present at Barclays Capital 2010 Healthcare Conference
|
March 05, 2010
BD Named Industry Champion on FORTUNE's List of the "World's Most Admired Companies"
|
March 01, 2010
BD Celebrates Opening of New Manufacturing Facility in San Luis Potosi, Mexico
|
February 23, 2010
BD Biosciences Launches BD FACSAria™ III Flow Cytometry System
|
February 08, 2010
BD Announces Worldwide Voluntary Recall of BD Q-Syte™ Luer Access Devices and BD Nexiva™ Closed IV Catheter Systems
|
February 08, 2010
BD Launches New Device Designed to Improve Safety, Accuracy and Turnaround Time of Blood Collection in Patients with Fragile Veins
|
February 03, 2010
BD Launches "Be a Flu Fighter" Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories
|
February 02, 2010
BD Board Declares Dividend
|
February 02, 2010
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 28, 2010
BD Announces Results for First Fiscal Quarter
|
January 27, 2010
BD Increases Haiti Relief Fund to Include $5 Million in Product Donations
|
January 19, 2010
JDRF and BD Collaborate to Improve Insulin Pump Delivery
|
January 15, 2010
BD Establishes $1.2 Million Fund for Haiti Earthquake Relief Efforts
|
January 14, 2010
BD Announces Webcast of Annual Meeting of Shareholders
|
January 11, 2010
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 11, 2010
BD Biosciences Collaborates with ReaMetrix to Develop New, Affordable CD4 Testing Products to Help Fight HIV/AIDS in Developing Countries
|
January 08, 2010
BD Applauds PEPFAR's Broadened Emphasis On Strengthening Health Systems
|
December 29, 2009
BD to Present at Investor Healthcare Conferences
|
December 08, 2009
BD Biosciences Announces First Winners of Expanded Research Grant Program
|
December 07, 2009
BD Expands Diagnostic Testing Offerings in Women's Health
|
November 24, 2009
BD Board Increases Dividend and Authorizes Additional Share Repurchases
|
November 19, 2009
BD Completes Acquisition of HandyLab, Inc.
|
November 05, 2009
BD Diagnostics Launches Turnkey Continuing Education Program for Clinical Laboratories
|
November 04, 2009
BD to Present at Investor Healthcare Conferences
|
November 04, 2009
BD Announces Results for Fourth Fiscal Quarter and Full Year
|
October 30, 2009
BD Director Emeritus Henry P. Becton, Sr. Dies at 95
|
October 23, 2009
BD Announces Agreement to Acquire HandyLab, Inc.
|
October 07, 2009
BD Ranked in the Top 100 Greenest Big Companies by Newsweek; Named Again to Dow Jones Sustainability World and North America Indexes
|
October 06, 2009
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 06, 2009
BD Announces FDA 510(k) Clearance of BD Vacutainer® Rapid Serum Blood Collection Tube
|
September 25, 2009
BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer
|
September 14, 2009
BD Launches Expanded Line of BD Visitec™ Single-Use Microsurgical Instruments and Customized Trays
|
September 03, 2009
BD Announces Flu Product Order from U.S. Government
|
August 25, 2009
NBA Legend Dikembe Mutombo, UNICEF Executive Director Ann M. Veneman and BD Commemorate Opening of New Center to Improve HIV/AIDS Treatment in the DRC
|
August 12, 2009
BD Biosciences Expands Reagent and Dye Portfolio for Cellular Analysis
|
August 11, 2009
BD and PEPFAR Collaboration Will Improve Blood-drawing Practices in Hospitals and Clinics in Sub-Saharan Africa
|
August 06, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio
|
August 04, 2009
BD Biosciences Launches Laboratory Information System Interface Software for Labs Using BD Flow Cytometers
|
August 04, 2009
BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn
|
July 29, 2009
BD Announces Results for Third Fiscal Quarter
|
July 28, 2009
BD Board Declares Dividend
|
July 23, 2009
BD Flu Preparedness Statement
|
July 19, 2009
BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/Aids and TB in Sub-Saharan Africa
|
July 09, 2009
New Flow Cytometry-based Methods for Stem Cell Research Presented at Annual International Society for Stem Cell Research Meeting
|
June 30, 2009
BD Biosciences Launches New Portfolio of Surfaces for Cell-Based Drug Discovery Screening and Basic Cell Culture Research
|
June 29, 2009
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 17, 2009
BD and FIND Achieve Milestone in Global Battle Against MDR-TB
|
June 01, 2009
BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research
|
June 01, 2009
BD to Present at Investor Healthcare Conferences
|
May 20, 2009
BD Board Declares Dividend
|
May 18, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
|
May 13, 2009
BD Biosciences Launches BD UltraPool™ HLM 150 Reagent
|
May 08, 2009
BD Extends Decade-Long Support for UNICEF's Campaign to Eliminate Maternal and Neonatal Tetanus
|
May 08, 2009
BD Biosciences Announces Winners of Annual Research Grant Program
|
May 08, 2009
BD Biosciences Expands Research Grant Program to Offer Researchers More Support During Tough Economic Times
|
May 04, 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
|
April 28, 2009
BD Announces Results for Second Fiscal Quarter
|
April 01, 2009
American Red Cross of Northern New Jersey Honors BD and President Vince Forlenza during April's "Touch of Red" Virtual Fundraising Gala
|
April 01, 2009
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 23, 2009
BD Announces FDA 510(k) Clearance of BD ProbeTec™ Qx Amplified Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
March 17, 2009
BD Launches BD OcuSeal™ Liquid Ocular Bandage
|
March 12, 2009
BD Joins Safe Injection Practices Coalition
|
March 11, 2009
BD Named to 100 Best Corporate Citizens List by CRO Magazine
|
March 11, 2009
BD Biosciences Facility in San Jose, California Achieves LEED Silver Certification
|
February 26, 2009
BD Soluvia™ Microinjection System Used For First Approved Intradermal Influenza Vaccine in the European Union
|
February 23, 2009
BD Ranks 23rd on EPA's Fortune 500 List of Green Power Purchasers
|
February 10, 2009
BD Announces CE Marking of BD ProbeTec™ Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
February 03, 2009
BD Board Declares Dividend
|
February 03, 2009
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 28, 2009
BD Announces Results for First Fiscal Quarter
|
January 14, 2009
New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Operating System now Available Worldwide
|
January 14, 2009
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 14, 2009
BD Announces Webcast of Annual Meeting of Shareholders
|
January 12, 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
|
December 23, 2008
BD to Present at Investor Healthcare Conferences
|
December 15, 2008
BD Biosciences Launches BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit
|
December 04, 2008
BD Receives FDA Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer
|
December 01, 2008
BD Launches 8mm BD AutoShield™ Pen Needle
|
November 25, 2008
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
|
November 25, 2008
BD Biosciences Announces Availability of New CD4 Technology in Africa
|
November 21, 2008
BD Increases Production Capacity for BD SafetyGlide™ Needles and Other Safety-Engineered Injection Devices
|
November 20, 2008
BD Announces Health Canada Licensing of Novel Molecular Assay for Detection of Clostridium difficile Toxin B Gene
|
November 08, 2008
BD Launches BD Atomic Edge™ Safety LRI Knives
|
November 05, 2008
BD Announces Results for Fourth Fiscal Quarter and Full Year
|
November 05, 2008
BD Announces Executive Appointments of President and Chief Financial Officer
|
November 03, 2008
BD to Present at Investor Healthcare Conferences
|
October 22, 2008
Collaborative Partnership Formed to Improve the Health of Health Care Workers
|
October 13, 2008
United Nations Secretary-General Statement Regarding HIV/AIDS (PDF)
|
October 03, 2008
BD Sponsors Campaign to Raise Awareness of XDR-TB (Extensively Drug-Resistant Tuberculosis)
|
October 02, 2008
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 02, 2008
BD Biosciences to Open New Animal-Free, Antibiotic-Free Cell Culture Media Manufacturing Facility
|
September 30, 2008
BD Breaks Ground on Major Manufacturing Facility in Tatabánya
|
September 25, 2008
Clinton Global Initiative Announces BD's Commitment To Biamba Marie Mutombo Hospital
|
September 23, 2008
Luminex and BD Sign Agreement to Create Diagnostic Tests for Cancer
|
September 10, 2008
BD Celebrates Opening of New Automated Warehouse in Fraga
|
July 24, 2008
BD Announces Results for Third Fiscal Quarter
|
July 22, 2008
BD Board Declares Dividend
|
July 07, 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
|
June 25, 2008
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 12, 2008
BD Biosciences and San Jose Mayor Celebrate Opening of State-of-the-Art Office Space and Customer Training Center
|
June 10, 2008
BD Celebrates Opening of New Manufacturing Center in Québec
|
June 04, 2008
BD Biosciences Earns Prestigious Life Science Industry Award for Best Flow Cytometry-based Cell Biology Instruments
|
June 03, 2008
BD to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
|
June 02, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections
|
May 23, 2008
BD Biosciences Launches BD AttoVision™ Software v1.6
|
May 20, 2008
BD Board Declares Dividend
|
May 13, 2008
BD Announces Acquisition of Cytopeia
|
May 07, 2008
BD to Present at Investor Healthcare Conferences
|
May 01, 2008
BD Announces CE Marking of the BD GeneOhm™ VanR Molecular Test for the Rapid Detection of Vancomycin Resistance
|
May 01, 2008
BD Biosciences Announces Agreement with 3-D Matrix to Market BD™ PuraMatrix™ Peptide Hydrogel Products to the Research Community
|
April 23, 2008
BD Announces Results for Second Fiscal Quarter
|
April 08, 2008
BD Opens New Manufacturing Facility in Suzhou, China to Produce Rapid Diagnostic Products
|
April 04, 2008
BD Biosciences Announces Winners of 2007 Research Grant Program
|
April 03, 2008
BD Biosciences Launches New BD™ High-Performance Calcium Dye Assay Kit
|
March 27, 2008
BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
|
March 26, 2008
BD Venflon™ Pro Safety Catheter Wins Award in Prestigious International Design Competition
|
March 26, 2008
BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
|
March 26, 2008
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 18, 2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
|
March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates
|
February 13, 2008
First European Application Filed for Product Using Innovative Intradermal Microinjection System BD Soluvia™
|
January 29, 2008
BD Board Declares Dividend
|
January 29, 2008
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 28, 2008
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
|
January 24, 2008
BD Announces Results for First Fiscal Quarter
|
January 18, 2008
BD Biosciences Launches New BD FACSAria™ II Cell Sorting System
|
January 16, 2008
BD Announces Webcast of Annual Meeting of Shareholders
|
January 04, 2008
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
December 27, 2007
BD to Present at the 26th Annual JPMorgan Healthcare Conference
|
December 20, 2007
BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens
|
December 18, 2007
UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent
|
November 21, 2007
Next Generation of BD Visitec™ Disposable Instruments Designed to Meet the Needs of Ophthalmic Surgery
|
November 20, 2007
BD Board Declares Dividend
|
November 07, 2007
BD to Present at Investor Healthcare Conferences
|
November 05, 2007
BD and FIND Help Address Emergence of XDR-TB With New Pricing Agreement for Liquid Culture System
|
November 02, 2007
BD Board of Directors Elects Cathy E. Minehan
|
November 01, 2007
BD Announces Results For Fourth Fiscal Quarter and Full Year
|
October 31, 2007
BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
|
October 22, 2007
CEO Ed Ludwig Discusses Healthcare-associated Infections on CNBC (Video)
|
October 09, 2007
BD Biosciences Opens Education Center in Rockville, Maryland for High-Content Bioimaging Customers
|
October 01, 2007
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
September 11, 2007
BD Announces FDA 510(k) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
|
September 08, 2007
New Ophthalmic Safety Knives with BD Atomic Edge™ Technology Approach Diamond-Like Sharpness and Single-Use Convenience
|
August 30, 2007
BD to Present at the Bear Stearns 20th Annual Healthcare Conference
|
August 06, 2007
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer
|
July 26, 2007
BD to Expand European Distribution Center in Temse, Belgium
|
July 26, 2007
BD Announces Results for Third Fiscal Quarter
|
July 24, 2007
BD Board of Directors Elects Marshall O. Larsen
|
July 24, 2007
BD Board Declares Dividend and Authorizes Additional Share Repurchases
|
June 29, 2007
BD Biosciences Releases BD FACSDiva™ 6.0 Software
|
June 29, 2007
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 28, 2007
BD Biosciences Announces 2007 Research Grant Program
|
June 15, 2007
BD Biosciences and StemCell Technologies Launch Advanced Culture Environment for Human Embryonic Stem Cell (hESC) Research
|
June 14, 2007
BD Medical - Ophthalmic Systems Celebrates 75 Years of Beaver Surgical Products
|
June 14, 2007
BD Biosciences and StemCell Technologies Sign License Agreements with WARF to Commercialize Novel Culture Media and Surfaces for Human Embryonic Stem Cell Research
|
June 04, 2007
BD and EPSC Announce Launch of specimencare.com
|
June 04, 2007
BD to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference
|
May 22, 2007
BD Board Declares Dividend
|
May 22, 2007
BD Demonstrates Microbiology Automation Designed to Improve Laboratory Efficiency of Microbial Identification and Susceptibility Testing
|
May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
May 18, 2007
BD to Present at the Bank of America 2007 Healthcare Conference
|
May 17, 2007
BD to Present at the Sanford C. Bernstein & Co., LLC Twenty-Third Annual Strategic Decisions Conference
|
May 10, 2007
BD Biosciences to Expand Manufacturing in Durham, North Carolina
|
April 27, 2007
BD Biosciences Earns Top Honors for Flow Cytometry-based Cell Biology Instruments at Prestigious Life Science Industry Awards
|
April 26, 2007
Variant Strain of Chlamydia May Go Undetected
|
April 25, 2007
BD Discloses Notice of Arbitration and Dispute Resolution Proceedings
|
April 25, 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
April 25, 2007
BD Announces Results for Second Fiscal Quarter
|
April 18, 2007
BD to Present at the 2007 Morgan Stanley Global Healthcare Unplugged Conference
|
March 28, 2007
BD Medical Launches the BD AutoShield™ Pen Needle
|
March 26, 2007
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 26, 2007
BD and Direct Relief International Launch Volunteer Service Program to Improve Healthcare in Ghana
|
March 22, 2007
BD and FIND Announce Expanded Collaboration to Improve Tuberculosis Diagnostics Worldwide
|
March 13, 2007
BD Move Signals Commitment to Oxford
|
March 09, 2007
BD Honored as One of "America's Most Admired Companies" in FORTUNE Magazine's Annual Rankings
|
March 01, 2007
BD to Present at the Cowen and Company 27th Annual Healthcare Conference
|
February 26, 2007
BD Biosciences and Roche Collaborate to Advance the Study of Cell Signal Transduction through New Phosphorylation Site Antibody Targets and Applications
|
February 14, 2007
BD Announces 2007 BD Biosciences Technology Days
|
February 08, 2007
BD Commits $34 Million for Major Expansion in Québec
|
February 07, 2007
BD Medical Creates BD FluStock(SM) Planning Service to Aid Pandemic Influenza Preparedness Efforts in Hospitals
|
January 30, 2007
BD Board Declares Dividend
|
January 30, 2007
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 30, 2007
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
|
January 25, 2007
BD Announces Results for First Fiscal Quarter
|
January 11, 2007
BD Announces Webcast of Annual Meeting of Shareholders
|
December 28, 2006
BD to Present at the 25th Annual JPMorgan Healthcare Conference
|
December 21, 2006
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
December 20, 2006
BD Completes Acquisition of TriPath Imaging
|
November 30, 2006
BD and International Council of Nurses Collaborate to Address the Health Human Resource Crisis in Africa
|
November 21, 2006
BD Board Declares Dividend
|
November 20, 2006
BD to Present at the Lazard Capital Markets Third Annual Life Sciences Conference
|
November 11, 2006
Responding to the Needs of the Ophthalmic Surgical Team: BD Provides Enhanced Safety Solutions
|
November 06, 2006
BD to Present at the ArgusVision 2007: Eyes on the Future Conference
|
November 02, 2006
BD Announces Results for Fourth Fiscal Quarter and Full Year
|
November 01, 2006
BD to Present at the CIBC World Markets Seventeenth Annual Healthcare Conference
|
October 30, 2006
BD Biosciences Announces Immunology Grant Program Winners
|
October 19, 2006
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 17, 2006
BD Medical Worksite Diabetes Prevention Program Yields Successful Results
|
September 28, 2006
BD Announces Plan to Exit Blood Glucose Monitoring Market
|
September 26, 2006
BD Board of Directors Elects Dr. Claire M. Fraser-Liggett
|
September 18, 2006
BD Biosciences Releases BD FACSCanto™ II Flow Cytometry System for In Vitro Diagnostics Use
|
September 14, 2006
BD Medical Extends Broader Offering of Needle Technology Designed to Improve Patient Comfort and Healthcare Worker Safety
|
September 08, 2006
BD to Acquire TriPath Imaging, Inc.
|
September 05, 2006
BD to Present at the Bear Stearns 19th Annual Healthcare Conference
|
August 31, 2006
BD to Present at the Thomas Weisel Partners Healthcare Conference 2006
|
August 14, 2006
BD Makes Filing to Report Bid to Acquire TriPath Imaging, Inc.
|
August 12, 2006
Research Shows CD4 Testing Cost-Effective for HIV Patients in Areas Lacking Access to Second-Line ARV Treatments
|
August 12, 2006
BD Diagnostics Announces Availability in Africa of New CD4 Stabilization Blood Collection Technology
|
August 09, 2006
BD Biosciences Empowers Advances in Immune System Disease Research
|
August 08, 2006
MedCentral Health System Implements BD.id™ Patient Identification System for Specimen Management
|
August 07, 2006
BD Biosciences Announces Extension of Grant Program for Immunology Researchers
|
July 28, 2006
CEO Ed Ludwig Discusses Third Fiscal Quarter Results on CNBC (Video)
|
July 28, 2006
BD Announces Results for Third Fiscal Quarter
|
July 25, 2006
BD Board of Directors Elects Dr. Adel A.F. Mahmoud
|
July 25, 2006
BD Board Declares Dividend
|
July 21, 2006
Wyeth Infant Meningitis Vaccine Available for Delivery with BD Hypak SCF™ Prefill System
|
July 18, 2006
BD Invests US$16 Million to Establish a Plant in China To Produce Rapid Diagnostic Products for Flu and Virus Infection
|
July 17, 2006
25 Years of Manufacturing Excellence in Plymouth
|
July 17, 2006
BD Medical Announces Positive Results for New York City BD Diabetes Makeover(SM) Program
|
June 15, 2006
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 15, 2006
BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper™ Robotic Instrumentation and Molecular Testing of Sexually Transmitted Infections
|
June 12, 2006
BD and Catholic Medical Mission Board Partner to Bolster Zambian Healthcare Clinics' HIV/AIDS Efforts
|
June 06, 2006
BD to Present at the Goldman Sachs 27th Annual Global Healthcare Conference
|
May 23, 2006
BD Board Declares Dividend
|
May 10, 2006
BD to Present at the Bank of America Healthcare Conference 2006
|
April 26, 2006
BD Announces Results for Second Fiscal Quarter
|
April 24, 2006
BD to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2006
|
April 12, 2006
BD Develops Its Global Manufacturing Centre in Drogheda
|
April 06, 2006
NYC's North General Hospital to Host BD Diabetes Makeover Program
|
March 28, 2006
BD Biosciences Announces Agreement with Dynomics to Collaborate on Novel Cancer Diagnostic Technology
|
March 27, 2006
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 20, 2006
BD Medical to Support Gary Hall, Jr. Through 2008 Olympic Games
|
March 06, 2006
BD to Present at the SG Cowen & Co. 26th Annual Health Care Conference
|
February 23, 2006
BD Diagnostics Announces Multi-year Agreement with Quest Diagnostics
for BD Viper™ System
|
February 17, 2006
BD Medical Notifies Blood Glucose Monitor Users in the US and Canada About a Potential Malfunction with its Meters
|
February 14, 2006
BD Completes Acquisition of GeneOhm Sciences, Inc.
|
January 31, 2006
BD Medical Continues Advancement of Flu Vaccine Delivery Technologies
|
January 31, 2006
BD Board Declares Dividend
|
January 30, 2006
BD Medical Announces New Regional Anesthesia Tray Business
|
January 26, 2006
BD Announces Results for First Fiscal Quarter
|
January 24, 2006
BD Announces Webcast of Annual Meeting of Shareholders
|
January 10, 2006
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 10, 2006
BD Announces Agreement to Acquire GeneOhm Sciences, Inc.
|
January 09, 2006
BD Diagnostics Announces FDA 510(k) clearance of the BD Viper™ System
|
January 04, 2006
BD Blood Glucose Monitors - Product Notification
|
December 28, 2005
BD to Present at the 24th Annual JPMorgan Healthcare Conference
|
December 21, 2005
BD Micro-Delivery System Licensed by Sanofi Pasteur
|
December 20, 2005
BD to Allow Poison Pill to Expire; also Adopts New Policy Regarding Election of Directors
|
December 13, 2005
BD Diabetes Makeover Program Continues to Yield Positive Results
|
November 22, 2005
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
|
November 10, 2005
BD Diagnostics and TimeMed Collaborate on First Notched Overlabel for Blood Collection Tubes
|
November 07, 2005
BD Biosciences to Establish Manufacturing in Puerto Rico
|
November 07, 2005
BD to Present at the 2005 Credit Suisse First Boston Health Care Conference
|
November 03, 2005
CEO Ed Ludwig Discusses Fourth Fiscal Quarter and Full Year Results on CNBC
|
November 03, 2005
BD Announces Results for Fourth Fiscal Quarter and Full Year
|
November 02, 2005
American Red Cross and BD Announce Expanded Collaboration to Support Measles Initiative
|
November 02, 2005
BD to Present at CIBC World Markets Healthcare Conference
|
October 28, 2005
BD Diabetes Makeover Teams with dLife Television
|
October 25, 2005
BD Expands Research and Data Hub in Research Triangle Park
|
October 19, 2005
BD Diagnostics Announces FDA 510(k) Clearance for BD ProbeTec™ Urine Preservative Transport
|
October 18, 2005
BD to Support TIME Global Health Summit, Nov. 1-3, 2005
|
October 05, 2005
Jackson-Madison County General Hospital to Implement BD.id™ Patient Identification System for Specimen Management
|
September 27, 2005
BD Diagnostics Announces FDA 510(k) Clearance of BD Directigen™ EZ Flu A+B Test
|
September 22, 2005
BD Announces Preparation Efforts Ahead of Hurricane Rita
|
September 20, 2005
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
September 14, 2005
BD Supplements Hurricane Katrina Relief Contribution with Medical Product Donations
|
September 01, 2005
BD Donates $500,000 to Hurricane Katrina Disaster Relief Efforts
|
September 01, 2005
BD to Present at Bear Stearns 18th Annual Healthcare Conference
|
August 30, 2005
BD to Present at Thomas Weisel Partners Healthcare Tailwinds Conference
|
August 22, 2005
BD Medical Continues Efforts to Advance Operating Room Safety
|
August 12, 2005
BD Diabetes Care Announces Successful Results of DC Diabetes Makeover Initiative
|
July 29, 2005
BD Announces Launch of Online Store
|
July 27, 2005
Single-Use Blood Collection Devices Help Ensure Safety of Patients and Healthcare Workers (PDF)
|
July 26, 2005
BD Board Declares Dividend
|
July 22, 2005
CEO Ed Ludwig Discusses Results on CNBC
|
July 22, 2005
BD Announces Results for Third Fiscal Quarter
|
July 13, 2005
BD Diabetes Makeover Program Comes to Nation's Capital
|
July 01, 2005
BD Announces Agreement to Sell Clontech
|
June 09, 2005
BD to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference
|
May 25, 2005
BD to Establish Major Distribution Center in Plainfield, Indiana
|
May 24, 2005
BD Board Declares Dividend
|
May 18, 2005
PreAnalytiX PAXgene™ Blood RNA System is Industry's First to Receive 510(K) Clearance From FDA and to Attain CE Mark
|
May 18, 2005
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
May 09, 2005
BD to Present at Banc of America Securities Health Care Conference 2005
|
May 04, 2005
BD and CMMB Join Forces to Address the Challenge of HIV/AIDS Pandemic in Zambia
|
May 04, 2005
BD to Present at R. W. Baird 2005 Growth Stock Conference
|
May 03, 2005
BD Announces Acquisition of Protein Separation Technology from FFE Weber GmbH
|
April 28, 2005
BD to Present at Morgan Stanley Third Annual Global Healthcare Conference
|
April 27, 2005
BD Announces Results for Second Fiscal Quarter
|
April 15, 2005
Pioneer in Blade Technology Introduces First Single-Use Cataract Safety Knife System
|
March 24, 2005
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 10, 2005
BD to Present at SG Cowen 25th Annual Health Care Conference
|
March 09, 2005
BD Announces Launch of Two New Monomeric Fluorescent Proteins for Life Science Researchers
|
February 23, 2005
BD Named One of America's Most Admired Companies in FORTUNE Magazine's Annual Survey
|
February 17, 2005
BD Commits $31 Million for Major Expansion in Sandy, Utah
|
February 02, 2005
BD to Present at Merrill Lynch 2005 Global Pharmaceutical, Biotechnology and Medical Device Conference
|
February 01, 2005
BD Announces Results of Shareholder Votes at Annual Meeting
|
February 01, 2005
BD Board Declares Dividend
|
January 28, 2005
BD Statement Regarding Worldwide Voluntary Recall of BD ProbeTec™ ET Urine Processing Kits
|
January 26, 2005
BD Announces Webcast of Annual Meeting of Shareholders
|
January 26, 2005
BD Announces Results for Fiscal First Quarter
|
January 20, 2005
BD to Present at 17th Annual Piper Jaffray Health Care Conference
|
January 14, 2005
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
|
January 10, 2005
BD Announces FDA 510(k) clearance of simplified test for detection of methicillin-resistant Staphylococcus aureus (MRSA)
|
January 05, 2005
BD to Present at 23rd Annual JPMorgan Healthcare Conference
|
January 04, 2005
BD Announces Tsunami Relief Efforts
|
December 20, 2004
BD Biosciences Supports World AIDS Day
|
December 16, 2004
Hindustan Latex and BD Launch Auto-Disable Syringes in India
|
December 15, 2004
FIND and BD Combine International Efforts to Improve Rapid Tuberculosis Diagnosis for HIV-positive Patients in Developing Countries
|
November 23, 2004
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
|
November 23, 2004
BD Board of Directors Elects Gary A. Mecklenburg
|
November 22, 2004
BD Releases New Version of BD.id™ Patient Identification System for Specimen Management
|
November 12, 2004
BD Commits to Major Expansion in Columbus, Nebraska
|
November 11, 2004
Meeting the Challenge of Influenza
|
November 09, 2004
Cellomics and BD Sign License Agreement to Further Expand Availability of High Content Screening
|
November 05, 2004
BD Presents Diabetes Makeover to Inspire Better Diabetes Care
|
November 04, 2004
BD Announces Fiscal Fourth Quarter and Full Year Results
|
November 04, 2004
FDA Alternate Site Clearance Offers BD Blood Glucose Meter Users More Convenience
|
October 26, 2004
BD to Present at CIBC World Markets Healthcare Conference
|
October 14, 2004
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 06, 2004
BD Launches Dora the Explorer™ Digital Thermometer
|
October 04, 2004
BD Announces Plan to Sell Clontech
|
September 21, 2004
BD Biosciences Releases BD FACSCanto™ Flow Cytometry System for Clinical Diagnostics
|
September 16, 2004
BD to Present at UBS Global Life Sciences Conference
|
September 07, 2004
BD to Present at Bear Stearns 17th Annual Healthcare Conference
|
September 02, 2004
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 Conference
|
September 01, 2004
2004 Olympic Gold-Medalist Swimmer Gary Hall Jr. Joins Forces with BD to Inspire Americans to Improve Their Diabetes Care
|
July 27, 2004
BD, Sumter County Announce Major Facility Expansion
|
July 27, 2004
BD Biosciences Pharmingen Designated One of the Best Workplaces for Commuterssm by U.S. EPA and DOT
|
July 27, 2004
BD Board Declares Dividend
|
July 22, 2004
BD Announces Results for Fiscal Third Quarter
|
July 12, 2004
BD Highlights Social Responsibility in First Global Corporate Citizenship Report
|
July 08, 2004
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
July 02, 2004
BD Announces Settlement of Pending Lawsuit
|
July 01, 2004
BD Announces Acquisition of Atto Bioscience, Inc.
|
June 29, 2004
BD Applauds President's Inclusion Of Vietnam In Global Strategy To Combat HIV/AIDS
|
June 28, 2004
BD FACSArray™ Bioanalyzer is Honored with a 2004 Silver Industrial Design Excellence Award
|
June 16, 2004
Norwalk Hospital to Implement BD.id™ Patient Identification System for Specimen Management
|
June 16, 2004
BD Receives Medical Design Excellence Award - Wireless Blood Glucose Monitor Recognized for Innovation, Design Excellence
|
June 14, 2004
BD Continues to Lead the Way in Drug Delivery Technologies: Launches New Generation of Plastic Prefillable Syringes
|
June 14, 2004
BD Names J. Peter Natale as Chief Information Officer
|
June 10, 2004
BD Submits 510(k) Application to FDA for Alternate Site Testing
|
June 02, 2004
BD to Present at Goldman Sachs Twenty Fifth Annual Global Healthcare Conference
|
May 25, 2004
BD Board Declares Dividend
|
May 24, 2004
BD Announces FDA 510(k) Clearance of Molecular Test for Legionella pneumophila
|
May 12, 2004
BD to Present at Banc of America Securities 2004 Health Care Conference
|
May 11, 2004
BD Biosciences Releases the BD FACSCanto™ Flow Cytometry System
|
May 04, 2004
BD™ Sharps Disposal By Mail System Meets EPA Guidelines, Helps Protect Public Against Injury, Infection
|
April 30, 2004
BD to Present at Morgan Stanley Second Annual Global Healthcare Unplugged Conference
|
April 22, 2004
BD Announces Fiscal Second Quarter Results
|
April 08, 2004
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 29, 2004
Basil L. Anderson Elected to BD Board of Directors
|
March 04, 2004
Hepatitis C Treatment Available in Self-Dosing Pen Format
|
February 26, 2004
BD to Present at the SG Cowen 24th Annual Health Care Conference
|
February 23, 2004
BD.id™ Patient Identification System Reduces Specimen Collection Errors by 99.95% at The Valley Hospital
|
February 04, 2004
BD Announces Launch of 1ml Retracting Syringe
|
January 29, 2004
BD Initiates Voluntary Recall of Certain BD™ Test Strips
|
January 29, 2004
BD Announces Fiscal First Quarter Revenue and Earnings Growth
|
January 28, 2004
BD to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
|
January 27, 2004
BD Board Declares Dividend
|
January 27, 2004
BD Board Authorizes Additional Share Repurchases
|
January 13, 2004
BD to Announce First Fiscal Quarter Results
|
December 29, 2003
BD Names Jeffrey S. Sherman Vice President and General Counsel
|
December 02, 2003
BD to Present at Merrill Lynch Medical Technology University Conference
|
November 24, 2003
BD Board Declares Dividend Increase of 50%
|
November 06, 2003
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues
|
November 06, 2003
BD Applauds Senate Action To Prevent Unsafe Medical Practices That Can Cause HIV/AIDS Spread In Africa
|
November 05, 2003
BD to Present at Credit Suisse First Boston's Health Care Conference
|
November 05, 2003
BD to Announce Fourth Fiscal Quarter and Year-End Results
|
November 04, 2003
BD to Present at the CIBC World Markets Fourteenth Annual Healthcare Conference
|
October 30, 2003
BD Supplemental Statement Regarding Voluntary Recall of BD ProbeTec™ ET Instrument
|
October 29, 2003
BD Introduces New BD Ultra-Fine™ II, Thinnest Insulin Syringe Needle Available In US
|
October 07, 2003
Park City Solutions Joins BD to Co-Market BD.id™ Patient Identification System
|
September 04, 2003
BD to Present at the Bear Stearns 16th Annual Healthcare Conference
|
August 29, 2003
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference
|
August 22, 2003
BD Statement Regarding Voluntary National Recall of BD ProbeTec™ ET Instrument
|
July 31, 2003
BD to Present at Adams, Harkness & Hill 23rd Annual Summer Seminar
|
July 24, 2003
BD Announces Results for Fiscal Third Quarter
|
July 22, 2003
BD Board Declares Dividend
|
June 30, 2003
BD to Announce Third Fiscal Quarter Results
|
June 05, 2003
BD to Present at Goldman Sachs Twenty Fourth Annual Global Healthcare Conference
|
May 20, 2003
BD Board Declares Dividend
|
May 01, 2003
BD to Present at the 2003 Deutsche Bank Securities Health Care Conference
|
April 25, 2003
BD Announces Fiscal Second Quarter Results
|
April 25, 2003
Webcast Replay - BD 2Q Earnings Conference Call, April 25, 2003, 8:30 AM ET
|
April 24, 2003
BD to Present at Morgan Stanley 1st Annual Healthcare Unplugged Conference
|
April 22, 2003
Edward F. DeGraan Elected to BD Board of Directors
|
April 16, 2003
BD Announces Plans for Discontinuation of Conventional Needle Sales in US Across Many Product Categories
|
April 15, 2003
BD CEO Edward J. Ludwig Selected to Serve on US-Japan Private Sector / Government Commission
|
April 02, 2003
BD to Announce Second Fiscal Quarter Results
|
March 18, 2003
BD to Present at the SG Cowen 23rd Annual Health Care Conference
|
March 14, 2003
BD Names Vincent A. Forlenza President of BD Biosciences
|
February 05, 2003
BD Comments Further on West Pharmaceutical Services Plant Incident
|
February 03, 2003
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
|
January 29, 2003
BD Statement in Response to West Pharmaceutical Services Plant Incident
|
January 28, 2003
BD Board Authorizes Additional Share Repurchases
|
January 28, 2003
BD Board Declares Dividend
|
January 23, 2003
BD Announces Results for Fiscal First Quarter
|
January 16, 2003
BD to Announce First Fiscal Quarter Results
|
January 08, 2003
BD Presents New Blood Glucose Monitoring Products and Announces Strategic Relationships with Medtronic MiniMed and Eli Lilly and Company
|
January 08, 2003
BD Introduces New Systems to Make Diabetes Monitoring and Management Easier, Faster, and Less Painful
|
December 10, 2002
BD to Present New Blood Glucose Monitoring Products
|
November 26, 2002
BD Board Declares Increased Dividend
|
November 06, 2002
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues
|
November 05, 2002
BD to Present at Credit Suisse First Boston Healthcare Conference
|
October 21, 2002
BD to Announce Fourth Fiscal Quarter and Year-End Results
|
October 16, 2002
NJ Governor announces agreement to pilot-test BD Bio-Terror Preparedness Network
|
September 24, 2002
Bertram L. Scott Elected to BD Board of Directors
|
September 23, 2002
BD™ Bifurcated Needle Launched for Smallpox Vaccination Efforts
|
September 04, 2002
BD Director Albert J. Costello Dies at 66
|
August 13, 2002
CEO and CFO submit certifications pursuant to SEC Order and Sarbanes-Oxley Act of 2002
|
August 12, 2002
CEO and CFO submit sworn statements pursuant to SEC Order regarding SEC filings
|
July 26, 2002
U.S. Fund for UNICEF and BD Partner to Accelerate Elimination of Maternal and Neonatal Tetanus
|
July 24, 2002
Letter to the Editor from Chairman, President and CEO Edward J. Ludwig in response to The New York Times article of July 19
|
July 24, 2002
BD Announces Results for Fiscal Third Quarter
|
July 23, 2002
BD Declares Dividend
|
July 19, 2002
Statement from BD in response to The New York Times article
|
May 30, 2002
BD Launches New Retracting Needle Syringe
|
May 21, 2002
BD Declares Dividend
|
April 24, 2002
BD Announces Record $1 Billion Second Quarter Revenues
|
April 16, 2002
BD Biosciences and NuGenesis Technologies Announce Strategic Alliance...
|
April 09, 2002
BD Announces New Safety-Engineered Product Technology
|
April 01, 2002
Wesley J. Howe, Former BD CEO, Dies at 80
|
March 26, 2002
BD to Present at Banc of America Securities Healthcare Conference
|
January 29, 2002
BD Biosciences Enters Into Collaboration With the Harvard Institute of Proteomics to Determine Human Gene Function
|
January 29, 2002
BD to Present at Merrill Lynch Healthcare Conference
|
January 23, 2002
BD Announces Results for Fiscal First Quarter
|
January 22, 2002
BD Declares Dividend
|
January 04, 2002
BD to Present at JP Morgan H&Q Healthcare Conference
|
January 03, 2002
BD to Announce First Fiscal Quarter Results
|
November 27, 2001
Edward J. Ludwig to Become BD Chairman of the Board Effective February 2002
|
November 27, 2001
BD Declares Increased Dividend
|
November 08, 2001
BD to Present at CSFB Health Care Conference
|
November 07, 2001
BD Announces Record Fiscal Fourth Quarter Revenues
|
October 30, 2001
BD to Announce Fourth Fiscal Quarter and Year-End Results
|
September 26, 2001
BD to Present at Bear Stearns Virtual Healthcare Conference
|
September 24, 2001
BD Pledges $1,000,000 to Help Victims and Families; Launches Worldwide Employee Contributions Campaign
|
September 17, 2001
BD Board Authorizes Additional Share Repurchases
|
September 04, 2001
BD to Present at Banc of America Securities Investment Conference
|
July 30, 2001
BD Biosciences To Collaborate With Zyomyx To Apply Antibody Expertise To High Density Protein Biochips
|
July 25, 2001
BD To Present at Adams, Harkness & Hill Summer Seminar
|
July 24, 2001
BD Declares Dividend
|
July 18, 2001
BD Announces Results For Fiscal Third Quarter
|
June 20, 2001
BD Congratulates GlaxoSmithKline on Receiving FDA Approval To Market Prefilled Vaccine System
|
June 13, 2001
BD Biosciences and Dyax Corp. Announce Research Products and Proteomics Alliance
|
June 07, 2001
BD To Present at Goldman Sachs Healthcare Conference
|
June 04, 2001
Nanogen/BD Joint Venture Awarded Its First U.S. Patent
|
June 01, 2001
BD Technologies Hosts Incubator Program Graduation Ceremonies
|
May 22, 2001
BD Declares Dividend
|
May 05, 2001
New UNICEF Greeting Card Celebrates a Mother's Love
|
April 18, 2001
BD Announces Record Revenues for Fiscal Second Quarter
|
April 04, 2001
BD Announces Plans To Introduce Passive, Shielded I.V. Catheter
|
March 22, 2001
BD To Present at Banc of America Securities Healthcare Conference
|
February 22, 2001
BD To Present at Lehman Brothers Healthcare Conference
|
February 01, 2001
BD To Present At Merrill Lynch Conference
|
January 23, 2001
BD Names Dean Paranicas Vice President, Investor Relations and Public Affairs
|
January 23, 2001
BD Declares Dividend
|
January 22, 2001
BD to Present at U.S. Bancorp Piper Jaffray Health Care Conference
|
January 17, 2001
BD Announces Results for Fiscal First Quarter
|
January 11, 2001
BD Announces Webcast of Q1 Conference Call
|
December 20, 2000
BD Signs Agreement to Acquire Gentest Corporation
|
December 15, 2000
Edward J. Ludwig Appointed to U.S. Fund for UNICEF Board of Directors
|
December 14, 2000
BD Names First Winners of Wesley J. Howe Award for Technological Innovation
|
November 28, 2000
BD Praises Recent California Patient Safety Legislation
|
November 28, 2000
BD Elects James Orr to Board of Directors
|
November 28, 2000
BD Declares Increased Dividend
|
November 13, 2000
BD to Present at CSFB Annual Healthcare Conference
|
November 06, 2000
President Clinton Signs Needlestick Safety and Prevention Act;
BD Celebrates Healthcare Worker Safety Law
|
November 06, 2000
BD Announces Record Revenues For Fiscal Fourth Quarter and Full Year
|
November 02, 2000
Live Web Cast of BD Presentation to Investment Community
|
October 27, 2000
BD Praises Senate Passage of Needlestick Safety and Prevention Act
|
September 26, 2000
BD Names Stephen Mock Vice President, Investor and Public Relations
|
September 26, 2000
BD Announces Program To Reduce Costs, Improve Financial Performance And Support Major Product Initiatives
|
September 20, 2000
BD Commends Introduction of New Needlestick Prevention Bill
|
August 14, 2000
Hepatitis B Immunization Campaign Launched in Indonesia Using BD Uniject™ Injection Device
|
July 25, 2000
BD Declares Dividend
|
July 20, 2000
BD Announces Results For Third Fiscal Quarter -- Safety and Biosciences Sales Add To Top Line Growth
|
July 19, 2000
BD Launches Safety Compliance Initiative for Needlestick Prevention
|
June 29, 2000
BD Applauds Consensus on Needlestick Prevention Legislation and Health Care Worker Safety at Congressional Hearing
|
June 05, 2000
BD Wins Major Patent Infringement Lawsuit
|
June 05, 2000
BD Names Bridget Healy General Counsel
|
May 30, 2000
BD Names John Considine Executive VP and Chief Financial Officer
|
May 23, 2000
BD Declares Dividend
|
April 25, 2000
Chlamydia and Gonorrhea Now Simple to Diagnose
|
April 24, 2000
BD Named Official Supplier by Major League Soccer (MLS)
|
April 19, 2000
BD Provides Unrestricted Grant to Support Needle Safety Campaign
|
April 18, 2000
BD Announces Strong Results for Second Fiscal Quarter and Confirms Outlook for Year
|
April 17, 2000
BD, Guidant, and Boston Scientific Join Leading Healthcare Companies
New E-Business Venture
|
April 13, 2000
"The Latest Injection and Blood Collection Advancements" featuring BD products on CNBC
|
March 21, 2000
Patient Safety at Your Fingertips; BD Develops Hand-Held Device Solutions to Reduce Medication Errors
|
February 24, 2000
Hospital Risk Managers Find Medication Error a Significant Problem; BD Survey Reveals Reporting Errors Not Rewarded
|
February 23, 2000
BD Expects Rapid Resumption of Product Supply Following Voluntary Recall; Offers Alternate Product at No Charge in Interim and Confirms E.P.S. Expectations
|
January 26, 2000
BD Declares Dividend
|
January 20, 2000
BD Reports Results for Fiscal First Quarter; Revenues Increase 12 Percent
|
January 06, 2000
New Jersey Governor Whitman Signs Needle Safety Bill
|
December 22, 1999
BD Makes Additional Contribution to UNICEF's Partnership to Eliminate Maternal and Neonatal Tetanus Worldwide
|
December 07, 1999
BD Helps Healthcare Organizations Reduce Medical Errors
|
November 23, 1999
BD Declares Increased Dividend
|
November 23, 1999
BD Names Robert M. Hallenbeck VP and General Counsel
|
November 22, 1999
BD Announces Edward J. Ludwig Elected to the Board of Directors and CEO
|
November 21, 1999
Bill and Melinda Gates Foundation Joins Unicef and BD in Effort To Prevent Newborn Deaths in Developing World
|
November 08, 1999
BD Announces FDA Clearance of BDProbeTec™ ET System For the Detection of Chlamydia and Gonorrhea
|
November 04, 1999
BD (Becton, Dickinson and Company) Announces Record Revenues for Fiscal Year
|
October 13, 1999
BD Announces Chief Financial Officer Is Leaving the Company
|
October 05, 1999
Becton, Dickinson and Company and Haselmeier GmbH Agree to Form Joint Venture
|
September 28, 1999
CIO Magazine Honors BD for Innovative Information Technology Practices
|
September 23, 1999
Two BD Products Win Design Excellence Awards
|
September 14, 1999
First Ever FDA-Cleared Breast Self-Examination Pad to Help Women Now Available in Drug Stores and Major Chains Nationwide
|
September 08, 1999
The International Diabetes Center and BD Fortify Staged Diabetes Management Collaboration
|
August 31, 1999
BD and QIAGEN Agree to form Joint Venture
|
August 31, 1999
BD Acquires SAF-T-MED Advanced Safety Needle Technology
|
August 26, 1999
Becton, Dickinson and Company Completes Acquisition of Clontech Laboratories, Inc.
|
August 18, 1999
Becton Dickinson Introduces a New Global Healthcare Brand
|
July 21, 1999
Becton Dickinson Reports Third Quarter Results
|
July 05, 1999
Gaida Joins BD Healthcare Consulting & Services
|
June 16, 1999
Becton Dickinson Announces National Agreement with Kaiser Permanente
|
June 11, 1999
Join Becton Dickinson at APIC'99
June 21-23, Hyatt Regency, Baltimore, MD
|
May 25, 1999
Becton Dickinson Names Ludwig President
|
May 25, 1999
Becton Dickinson Announces Election of Willard J. Overlock, Jr.
|
May 12, 1999
Becton Dickinson Introduces The MICROTAINER® Brand GENIE™ Lancet
|
May 03, 1999
BD Labware and Kimble/Kontes announce the formation of a collaborative agreement.
|
April 28, 1999
Becton Dickinson and Company Announces Planned Acquisition of Clontech Laboratories, Inc.
|
April 09, 1999
Becton Dickinson Enters Into Collaborative Drug Delivery Agreements with Rhône-Poulenc Rorer
|
March 15, 1999
Becton Dickinson Presents Award at LabAutomation99
|
March 15, 1999
Becton Dickinson Biosciences Leukemia and Lymphoma Product Development Team Volunteers Time at Leukemia Society of America's Cure-a-Thon
|
March 09, 1999
B-D.id and CAP Today Co-Sponsor Survey to Determine Awareness of Medication Administration and Specimen Collection Errors
|
March 01, 1999
Becton Dickinson Expands Growing Anesthesia Business With Acquisition of Kendall Anesthesia Product Line
|
February 25, 1999
BD Enters Molecular Oncology Alliance with Millennium Predictive Medicine
|
February 09, 1999
Becton Dickinson and Company Announces the Acquisition of Biometric Imaging
|
February 04, 1999
Becton Dickinson Supports Operation Smile's "World Journey of Hope '99"
|
February 04, 1999
Becton Dickinson Introduces Plastic-Coated Micro-Hematocrits
|
February 02, 1999
Becton Dickinson Introduces Quikheel™ Lancets for Infants and Preemies
|
February 02, 1999
Becton Dickinson Introduces the VACUTAINER® Brand ECLIPSE™ Blood Collection Needle
|
January 26, 1999
Becton Dickinson Acquires Luther Medical Products
|
January 26, 1999
Becton Dickinson Declares Dividend
|
January 21, 1999
Asia's Largest Hypodermic Manufacturing Facilities Established In Bawal, Haryana
|
January 21, 1999
Becton Dickinson Reports 16 Percent E.P.S. Increase For Fiscal First Quarter; Revenues Increase 10 Percent
|
January 01, 1999
BD to Present at CIBC World Markets Healthcare Conference
|
December 14, 1998
Becton Dickinson Acquires New Advanced Protection Technology
|
November 23, 1998
Becton Dickinson Declares Increased Dividend
|
November 13, 1998
Castellini Receives Award in Singapore
|
November 05, 1998
Becton Dickinson Announces Record Revenues For Fiscal Year
|
October 22, 1998
Becton Dickinson Donation Supports Romanian Measles Elimination Campaign
|
September 03, 1998
Becton Dickinson Creates Single Bioscience/Diagnostic Business
|
August 14, 1998
Becton Dickinson Selected by IndustryWeek Magazine as One of the World's 100 Best-Managed Companies
|
August 05, 1998
Becton Dickinson and Company Announces Executive Vice Presidents; New Chief Financial Officer Named
|
July 28, 1998
Becton Dickinson Declares Stock Split and Quarterly Dividend
|
July 21, 1998
Becton Dickinson Reports Third Quarter Results; Record Revenues Increase 18 Percent
|
June 07, 1998
A Partnership in Diabetes - Becton Dickinson Employees Walk in JDF Walkathon
|
May 20, 1998
Becton Dickinson Announces Election of Alfred Sommer to Board of Directors
|
May 19, 1998
Becton Dickinson and Company Announces Restructuring Plan, One-Time Charges For Third Fiscal Quarter
|
May 19, 1998
Becton Dickinson Declares Dividend
|
May 11, 1998
New BACTEC™ MGIT™ 960 Is The World's First Automated System For High-Volume Mycobacteria Growth, and Detection
|
April 21, 1998
Becton Dickinson Reports 13 Percent E.P.S. Increase For Fiscal Second Quarter; Revenues Grew Six Percent
|
April 03, 1998
Becton Dickinson Completes Acquisition of Medical Devices Division of The BOC Group
|
March 20, 1998
Incoming chairman says FDA Modernization Act has 'opened door' to new challenges
|
March 20, 1998
Becton Dickinson Engineers Team Up with Students in 1998 FIRST Robotics Competition
|
March 13, 1998
Becton Dickinson and Company Introduces the B-D™ ULTRA-FINE™ II Lancet
|
January 29, 1998
Becton Dickinson Signs Definitive Agreement to Acquire Medical Devices Division of the BOC Group
|
January 27, 1998
Becton Dickinson and Baxter Announce Joint Marketing Effort
|
January 26, 1998
Becton Dickinson Acquires Tru-Fit
|
January 22, 1998
Becton Dickinson Announces Record Fiscal First Quarter Results
|
December 22, 1997
Five-Year Contract Signed With SmithKline Beecham
|
December 08, 1997
Becton Dickinson Joins EPA's Energy Star Program
|
November 25, 1997
Becton Dickinson Declares Increased Dividend
|
November 06, 1997
Becton Dickinson Announces Record Results For Fiscal Year
|
October 27, 1997
Becton Dickinson Sponsors China's First Five-Year Diabetes Education Program
|
October 20, 1997
Galiardo Briefs Investors On Industry Issues
|
September 15, 1997
Centennial Celebration in Franklin Lakes, New Jersey
|
September 11, 1997
FDA Clears Becton Dickinson Diabetes Measurement Kit For Marketing
|
September 09, 1997
Bell Rings for BDX at the NYSE Close
|
July 22, 1997
Becton Dickinson Initiates Compass Project
|
July 22, 1997
Becton Dickinson Declares Dividend
|
July 21, 1997
Becton Dickinson Reports Third Quarter Results; One-Time Charges Reduce E.P.S. By $.11
|
June 02, 1997
Becton Dickinson Announces Completion of Acquisition of Difco Laboratories
|
May 28, 1997
Willard Scott of the Today Show sings "Happy Birthday" to us!
|
May 27, 1997
Becton Dickinson Announces Election of Margaretha af Ugglas to Board of Directors
|
May 20, 1997
Becton Dickinson Declares Dividend
|
May 19, 1997
Becton Dickinson and Pharmingen Announce Completion of Acquisition
|
April 17, 1997
Becton Dickinson Reports 15 Percent E.P.S. Increase for Fiscal Second Quarter
|
April 10, 1997
Three Named as Honorees in 1997 Tribute to Women and Industry (TWIN)
|
April 10, 1997
Becton Dickinson and Company Signs Definitive Agreement to Acquire PharMingen
|
March 26, 1997
Becton Dickinson Sponsors Student Team in FIRST Competition
|
March 19, 1997
Becton Dickinson and Company Signs Definitive Agreement to Acquire Difco Laboratories Incorporated
|
January 22, 1997
Becton Dickinson Reports 31 Percent Net Income Increase for Fiscal First Quarter
|
January 21, 1997
BDSCS Launches ONES Initiative
|
December 04, 1996
Sandy Facility First To Receive ISO 14001 Certification
|
November 12, 1996
Fresenius Buys Vial Medical Infusion Systems
|
November 07, 1996
Becton Dickinson Announces Record Results for Fiscal Year
|
November 05, 1996
Community Service Awards Announced
|
November 01, 1996
Opening Ceremonies Held in China
|
October 24, 1996
Investment in India Increased to $100 Million
|
October 04, 1996
BDRC Scientist Recognized
|
